Michael Dacks

Michael Dacks

Fondatore presso Type 2 Ventures Ltd.

47 anni
Process Industries
Consumer Services
Health Technology

Profilo

Michael Dacks is the founder of Midatadin.com Ltd.
(founded in 2013) and Type 2 Ventures Ltd.
(founded in 2019).
He is currently the President & Chief Operating Officer at Psyence Therapeutics Corp.
(since 2020).
He previously held positions at Vertical Peak Holdings, Inc. as an Independent Director, MedReleaf Corp.
as VP-Legal & International Business Affair (2016-2018), Plena Global Holdings, Inc. as Senior Vice President-Global Affairs (2018-2019), StateHouse Holdings, Inc. as Director (2020-2021), and Psyence Group, Inc. as Chief Operating Officer (2020-2021).
Mr. Dacks received his undergraduate degree from the University of Western Ontario in 1998 and his graduate degree from Osgoode Hall Law School in 2004.

Posizioni attive di Michael Dacks

SocietàPosizioneInizio
Type 2 Ventures Ltd. Fondatore 01/04/2019
Psyence Therapeutics Corp. Presidente 01/08/2020
Tutte le posizioni attive di Michael Dacks

Precedenti posizioni note di Michael Dacks

SocietàPosizioneFine
STATEHOUSE HOLDINGS INC. Direttore/Membro del Consiglio 31/12/2021
PSYENCE GROUP INC. Direttore operativo 01/02/2021
Corporate Officer/Principal 01/07/2019
MEDRELEAF CORP Consigliere Generale 02/09/2018
Midatadin.com Ltd. Fondatore 01/07/2016
Vedi nel dettaglio l'esperienza di Michael Dacks

Formazione di Michael Dacks

University of Western Ontario Undergraduate Degree
Osgoode Hall Law School Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael Dacks

Relazioni

100 +

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
VERTICAL PEAK HOLDINGS INC.

Process Industries

STATEHOUSE HOLDINGS INC.

Process Industries

PSYENCE GROUP INC.

Industrial Services

Aziende private5

Health Technology

Process Industries

Midatadin.com Ltd.

Type 2 Ventures Ltd.

Psyence Therapeutics Corp.

Vedi le connessioni aziendali